Appeal No. 1997-4395
Application No. 08/351,044
reasonable correlation to the scope of enablement provided by
the disclosure. Enablement is also not precluded even if some
experimentation is necessary, although the amount of experi-
mentation needed must not be unduly excessive. Hybritech,
Inc. v. Monoclonal Antibodies Inc., 802 F.2d 1367, 1384, 231
USPQ
81, 94 (Fed. Cir. 1986), cert. denied, 480 U.S. 947 (1987).
Generally, for the reasons set forth by the appellants in
the brief and the reply brief, we reverse the rejection. As
the brief and reply brief attempt to make clear, the Board did
not find, contrary to the examiner's view, that the entire
specification was not enabling for any detection, no matter
how claimed, of subsequent skips.
As a starting point, each of the independent claims 32,
39 and 46 presently on appeal contains language in some manner
at the end of each of them relating to the resynchronization
of the stated measured elapsed time signal to correspond with
the reported elapsed time signal upon the occurrence of the
determination of a skip so that subsequent skips can be
4
Page: Previous 1 2 3 4 5 6 7 8 9 10 Next
Last modified: November 3, 2007